Browse studies

Find your next paid study

136 recruiting studies matching your filters

A Phase IIa Open Label Study Evaluating the Preliminary Efficacy of Intratumoural Tigilanol Tiglate in Advanced and/or Metastatic Soft Tissue Sarcoma of the Extremities and Body Wall.

A Phase IIa open label study evaluating the preliminary efficacy of intratumoural tigilanol tiglate in advanced and/or metastatic soft tissue sarcoma of the ex…

Soft Tissue Sarcoma

Estimated

~$75 – $2,800

Actual pay is set by the research site.

QBiotics Group LimitedNCT05755113

Phase 1

A Phase I Open-Label, Dose Escalation Study of the Safety and Tolerability of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

This is a Phase 1, multicenter, open-label dose escalation study to determine the safety and tolerability of intratumoral (IT) injection of tolododekin alfa (A…

Advanced Solid TumorCutaneous TumorSubcutaneous Tumor+6 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Ankyra Therapeutics, IncNCT06171750

Phase 3

An Open Label Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD)

This is an open label extension (OLE) study of an ongoing randomized controlled parent clinical studies 218224 (NCT05878717) and 221672 (NCT06572384) which aim…

Connective Tissue Diseases

Estimated

~$50 – $2,250

Actual pay is set by the research site.

GlaxoSmithKlineNCT06716606

Phase 2

Phase 2 Trial of Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)

The purpose of this study is to assess if an investigational treatment of Epcoritamab will be beneficial for patients with Marginal Zone Lymphoma (MZL).

Marginal Zone LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueSplenic Marginal Zone Lymphoma+1 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Izidore Lossos, MDNCT06796998

Observational

AFTERCARE: Automatic Versus Family-directed Transition Follow-up After Hospitalization: Evaluating Randomization, Caregiver Acceptability, and Recruitment fEasibility

Children with medical complexity often receive a recommendation to see an outpatient clinician soon after leaving the hospital. It is uncertain whether every c…

Children With Medical ComplexityRespiratory Tract Infections (RTI)Urinary Tract Infection (UTI)+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Seattle Children's HospitalNCT07864636

De-identified Human Tissue Project for Use with Translational, Biomedical Research At UCF College of Medicine and Burnett School of Biomedical Sciences

Research scientists of the University of Central Florida College of Medicine (COM) and Burnett School of Biomedical Sciences (BSBS) conduct laboratory studies …

Tissue

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Central FloridaNCT06082687

PRECISE: A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons

The objective of this study is to evaluate the Symani System's safety and effectiveness for microsurgical anastomosis during free tissue transfer surgery and l…

Open SurgeryLymphedemaFree Tissue Transfer+2 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

MMI (Medical Microinstruments, Inc.)NCT06725030

Observational

Clinical Feasibility and Potential Clinical Benefit of 68Ga-DOTATATE PET/CT Assessment of Soft Tissue Sarcomas for Potential Peptide Receptor Radionuclide Therapy

This trial studies how well 68Ga-DOTATATE digital PET/CT work in diagnosing soft tissue sarcoma. 68Ga-DOTATATE is a radiotracer that may improve image quality …

Soft Tissue Sarcoma

Estimated

~$10 – $750

Actual pay is set by the research site.

Ohio State University Comprehensive Cancer CenterNCT06500065

Phase 2

Abemaciclib for Treatment of Advanced Bone and Soft Tissue Sarcoma Identified as Having CDK Pathway Alteration

This is a single-arm, phase II study that will enroll a total of 45 subjects. All subjects will have a confirmed diagnosis of metastatic or unresectable soft t…

ChondrosarcomaOsteosarcomaSoft Tissue Sarcoma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Medical College of WisconsinNCT04040205

Registry of Myriad™ Utilization in Soft Tissue Reconstruction Procedures

This is an observational study designed to evaluate the safety and clinical outcomes of Myriad™ in soft tissue reconstruction procedures. The study will enroll…

Abdominal Wound DehiscenceNecrotizing Soft Tissue InfectionLower Extremity Wound+4 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Aroa Biosurgery LimitedNCT05243966

Phase 1

Phase 1 Study of the Administration of T Lymphocytes Expressing the Kappa Chimeric Antigen Receptor (CAR) and CD28 Endodomain for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

This study will combine both T cells and antibodies in order to create a more effective treatment. The treatment tested in this study uses modified T-cells cal…

Mantle Cell LymphomaFollicular LymphomaSplenic Marginal Zone Lymphoma+3 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

UNC Lineberger Comprehensive Cancer CenterNCT04223765

Phase 1

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

The study participant has been diagnosed with non-rhabdomyosarcoma (NRSTS). Primary Objectives Intermediate-Risk * To estimate the 3-year event-free surviva…

Adipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma+39 more